Microorganisms in Recent Drug Discovery

Environmental microbes are a significant source of drug discovery, and several microbial products (anti-tumor products, immunosuppressant, antibiotics and others) are routinely used for human therapy. Most of these products were obtained from cultivable environmental microbes, and this means that the vast majority of microbes were not targeted for drug discovery. With the advent of new and emerging technologies, we are poised to harvest novel drugs from the so-called 'uncultivable' microbes. In this article, we propose how a multidisciplinary approach combining different technologies can expedite and revolutionize drug discovery from uncultivable microbes and examine the current limitations of technologies and strategies to overcome such limitations that might further expand the promise of drugs from environmental microbes.

  • Novel species discovery
  • Novel species discovery
  • Genetically modified organisms

Related Conference of Microorganisms in Recent Drug Discovery

March 17-18, 2025

54th World Congress on Microbiology

Berlin, Germany
July 28-29, 2025

17th International Virology Summit

Berlin, Germany
August 25-26, 2025

6th International Conference on Molecular Microbiology

Singapore City, Singapore
September 22-23, 2025

13th World Congress and Expo on Applied Microbiology

Dubai, UAE

Microorganisms in Recent Drug Discovery Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in